08048035968
Leading Indian Pharma Exporter of NUPARP 200mg Tablets to Singapore – Tampines | Phoenix Exim

1. General Information

NUPARP 200 mg Tablets are an oncology medicine containing rucaparib, which works by interfering with DNA-repair processes in cancer cells. It is prescribed for selected patients with certain ovarian, fallopian tube, primary peritoneal, and prostate cancers, depending on the cancer type, previous treatment, and relevant genetic or biomarker findings.

Exporter information: Phoenix Exim, Nagpur, India, supplies pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable regulatory and import requirements.

2. Product Information

  • Brand: NUPARP 200 mg Tablets
  • Active ingredient: Rucaparib
  • Strength: 200 mg
  • Dosage form: Tablet
  • Therapeutic class: Anticancer / PARP inhibitor
  • Route: Oral
  • Pack information: Commonly supplied as 60 tablets per bottle
  • Manufacturer/Marketer: Zydus Lifesciences Ltd.
  • Prescription status: Prescription medicine

3. Uses of NUPARP 200 mg

NUPARP may be prescribed for certain forms of:

  • Ovarian cancer
  • Fallopian tube cancer
  • Primary peritoneal cancer
  • Certain prostate cancers

Its use depends on factors such as previous chemotherapy, response to treatment, disease status, and specific genetic or molecular characteristics. It should only be used according to an oncologist's prescription.

4. Benefits of This Medicine

The potential benefits of rucaparib therapy include:

  • Helps inhibit cancer-cell DNA repair.
  • May help control the growth and survival of susceptible cancer cells.
  • Can be used as maintenance treatment in selected patients after an appropriate response to chemotherapy.
  • Provides a targeted treatment approach for cancers with particular DNA-repair deficiencies or approved biomarkers.
  • May offer an oral treatment option for eligible oncology patients.

Important: The effectiveness of NUPARP varies between patients and depends on the specific cancer and clinical circumstances.

5. Side Effects of NUPARP 200 mg

Like other anticancer medicines, NUPARP can cause side effects. Possible adverse effects include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Fatigue or weakness
  • Reduced appetite
  • Headache
  • Changes in blood-cell counts
  • Liver-related abnormalities

Some adverse effects can be serious. Patients should promptly contact their treating doctor if they develop unusual bleeding, persistent fever or infection, severe weakness, breathing difficulties, or other concerning symptoms.

6. Common Side Effects

Commonly reported effects include:

  1. Nausea
  2. Tiredness or weakness
  3. Vomiting
  4. Diarrhea
  5. Constipation
  6. Decreased appetite
  7. Headache
  8. Changes in blood counts

The severity and frequency can vary from person to person.

7. How to Use NUPARP 200 mg

  • Take NUPARP exactly as prescribed by your oncologist.
  • It may generally be taken with or without food.
  • Swallow the tablet whole with water.
  • Do not crush, chew, or break the tablet unless specifically instructed by your healthcare professional.
  • Take doses at approximately the same times each day.
  • Do not change the dose or stop treatment without consulting your doctor.

The appropriate dosing schedule can vary according to the indication, response, tolerability, and other medical factors.

8. How NUPARP 200 mg Works

NUPARP contains rucaparib, which inhibits PARP enzymes involved in repairing damaged DNA. By interfering with DNA-repair mechanisms, rucaparib can make it difficult for certain cancer cells—particularly cells with existing DNA-repair defects—to survive and multiply.

This mechanism is known as PARP inhibition and forms part of a targeted approach to treating selected cancers.

9. Safety Advice

  • Prescription only: Use only under specialist medical supervision.
  • Blood monitoring: Your doctor may regularly monitor blood counts because treatment can cause reductions in blood cells.
  • Liver monitoring: Liver function may need periodic monitoring.
  • Pregnancy: Rucaparib may harm an unborn baby and should not be used during pregnancy unless specifically directed by a specialist.
  • Breastfeeding: Breastfeeding should be avoided during treatment and for the period recommended by your treating doctor after the final dose.
  • Drug interactions: Inform your doctor about all prescription medicines, OTC medicines, vitamins, and supplements you take.
  • Allergies: Do not use it if you have a known allergy to rucaparib or any component of the product.
  • Children: Safety and effectiveness have not been established for routine pediatric use.
  • Do not self-medicate: This is a specialized anticancer medicine and should be used only for the indication and dose prescribed by an oncologist.

10. FAQs

Q1. What is NUPARP 200 mg used for?
NUPARP contains rucaparib and is used for selected ovarian, fallopian tube, primary peritoneal, and prostate cancers depending on the patient's clinical and molecular characteristics.

Q2. What is the active ingredient in NUPARP 200 mg?
The active ingredient is rucaparib 200 mg.

Q3. Is NUPARP 200 mg a chemotherapy medicine?
It is an oral targeted anticancer medicine belonging to the PARP inhibitor class. It works differently from traditional cytotoxic chemotherapy.

Q4. Can NUPARP 200 mg be taken with food?
It can generally be taken with or without food. Follow the specific instructions given by your oncologist.

Q5. Can I stop NUPARP when I feel better?
No. Do not stop or change treatment without consulting your oncologist.

Q6. What should I do if I miss a dose?
Follow your prescribing doctor's instructions. Do not take an extra dose to compensate unless your healthcare professional specifically tells you to.

Q7. Does NUPARP require a prescription?
Yes. NUPARP is a prescription anticancer medicine.

Q8. Who manufactures NUPARP 200 mg?
NUPARP 200 mg is marketed by Zydus Lifesciences Ltd.

11. Substitute for NUPARP 200 mg

Potential alternatives containing rucaparib 200 mg include brands such as:

  • Ruparib 200 mg
  • Rucaza 200 mg
  • Bdparib 200 mg

Availability varies by country and market. A substitute should not be selected solely on the basis of the brand name; the prescribing oncologist should confirm that the active ingredient, strength, formulation, indication, and quality are appropriate.

12. SEO Keywords

Primary keywords:

  • NUPARP 200 mg Tablets
  • NUPARP 200 mg
  • NUPARP 200 mg Tablets exporter
  • NUPARP 200 mg supplier from India
  • Rucaparib 200 mg Tablets
  • Rucaparib 200 mg exporter
  • Rucaparib tablets supplier India
  • NUPARP 200 mg pharmaceutical exporter
  • NUPARP 200 mg oncology medicine
  • NUPARP 200 mg anticancer tablets

Long-tail B2B keywords:

  • Buy NUPARP 200 mg Tablets from India
  • NUPARP 200 mg Tablets pharmaceutical supplier India
  • NUPARP 200 mg Tablets exporter from Nagpur India
  • Rucaparib 200 mg Tablets exporter from India
  • Genuine NUPARP 200 mg Tablets supplier
  • NUPARP 200 mg oncology medicine exporter
  • NUPARP 200 mg Tablets wholesale supplier
  • NUPARP 200 mg Tablets international pharmaceutical exporter
  • NUPARP 200 mg supplier for USA
  • NUPARP 200 mg supplier for UK
  • NUPARP 200 mg supplier for Australia
  • NUPARP 200 mg supplier for Singapore
  • NUPARP 200 mg supplier for Canada
  • NUPARP 200 mg supplier for South Korea
  • NUPARP 200 mg supplier for UAE
  • Rucaparib 200 mg oncology medicine exporter from India
  • NUPARP 200 mg cancer medicine supplier India
  • NUPARP 200 mg tablets wholesale pharmaceutical supplier
  • Indian pharmaceutical exporter of NUPARP 200 mg
  • NUPARP 200 mg tablets global supply from India
Aug 21st, 2026 12:42 PM

Keywords